2020
DOI: 10.12659/msm.926254
|View full text |Cite
|
Sign up to set email alerts
|

The Protein Kinase R Inhibitor C16 Alleviates Sepsis-Induced Acute Kidney Injury Through Modulation of the NF-κB and NLR Family Pyrin Domain-Containing 3 (NLPR3) Pyroptosis Signal Pathways

Abstract: Background Protein kinase R (PKR) is implicated in the inflammatory response to bacterial infection while the role of PKR in sepsis-induced acute kidney injury (AKI) is largely unknown. This study aimed to investigate the effects of the specific PKR inhibitor C16 (C13H8N4OS) on lipopolysaccharide (LPS)-induced AKI, and its mechanisms of action. Material/Methods C57BL/6J mice were injected intraperitoneally with C16 or vehicle 1 h before the LPS challenge and then inject… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(15 citation statements)
references
References 31 publications
0
15
0
Order By: Relevance
“…LPS was previously reported to induce the production of TNFα and IL-6 in kidneys of normal rats, and this effect was likely to be aggravated after renal intravenous administration of Ang II (Niimi et al, 2002). LPS stimulates NF-κB, mitogen-activated protein kinase (MAPK) family, and other signals to transmit into cells through binding with CD14 and TLR4, inducing the release of a large number of inflammatory factors, such as TNF-α, IFN-γ, IL-1, IL-6, and IL-12 (Smith et al, 2015;Patel et al, 2019;Zhou et al, 2020). These inflammatory factors are generally signal molecules and effectors that directly result in "inflammatory storm" through the NF-κB pathway, leading to cell damage.…”
Section: Discussionmentioning
confidence: 99%
“…LPS was previously reported to induce the production of TNFα and IL-6 in kidneys of normal rats, and this effect was likely to be aggravated after renal intravenous administration of Ang II (Niimi et al, 2002). LPS stimulates NF-κB, mitogen-activated protein kinase (MAPK) family, and other signals to transmit into cells through binding with CD14 and TLR4, inducing the release of a large number of inflammatory factors, such as TNF-α, IFN-γ, IL-1, IL-6, and IL-12 (Smith et al, 2015;Patel et al, 2019;Zhou et al, 2020). These inflammatory factors are generally signal molecules and effectors that directly result in "inflammatory storm" through the NF-κB pathway, leading to cell damage.…”
Section: Discussionmentioning
confidence: 99%
“…These included two pathways with established roles in AKI [28,29]: the glycoprotein VI (GP6) signalling pathway (pro-inflammatory, activated between Baseline and ADHF), and the acute phase response signalling pathway (proinflammatory, inhibited between ADHF and Recovery). Enriched pathways previously implicated in AKI that were repressed between Baseline and ADHF included the xenobiotic pregnane X receptor (PXR) signalling pathway (anti-inflammatory) [30,31], the xenobiotic metabolism aryl hydrocarbon receptor (AHR) signalling pathway (anti-proliferation, proinflammatory) [32,33], the peroxisome proliferator-activated receptor alpha (PPARα/RXRα) pathway (anti-inflammatory) [34,35], and the protein kinase R (PKR) in interferon induction and antiviral response pathway (pro-apoptotic, pro-inflammatory) [36,37]. The coagulation system, also implicated in AKI [38,39], was activated between Baseline and ADHF.…”
Section: Pathway Activation and Inhibitionmentioning
confidence: 99%
“…The coagulation system, also implicated in AKI [38,39], was activated between Baseline and ADHF. metabolism aryl hydrocarbon receptor (AHR) signalling pathway (anti-proliferation, proinflammatory) [32,33], the peroxisome proliferator-activated receptor alpha (PPARα/RXRα) pathway (anti-inflammatory) [34,35], and the protein kinase R (PKR) in interferon induction and antiviral response pathway (pro-apoptotic, pro-inflammatory) [36,37]. The coagulation system, also implicated in AKI [38,39], was activated between Baseline and ADHF.…”
Section: Pathway Activation and Inhibitionmentioning
confidence: 99%
“…Furthermore, several in vivo studies using mice and rats have examined the effect of C16 in disease contexts such as inflammation, neurodegeneration, obesity, hypertension, cancer, and diabetes (170-184) (Table 2). Importantly, numerous groups have shown that C16 is protective of LPS-induced pathogenesis in mice, including acute lung injury, bone destruction, skeletal muscle atrophy, and acute kidney injury (177)(178)(179)(180)(181). Since LPS is a major cell wall component of Gram-negative bacteria, these findings suggest that C16 could protect against excessive inflammation and tissue damage during bacterial infections.…”
Section: Pkr Inhibitorsmentioning
confidence: 99%